Molecular modelling and quantitative structure-activity relationship studies on the interaction of omeprazole with cytochrome P450 isozymes
- 1 January 1998
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 125 (1) , 31-44
- https://doi.org/10.1016/s0300-483x(97)00159-5
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- [14] Assays of omeprazole metabolism as a substrate probe for human CYP isoformsPublished by Elsevier ,1996
- Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismBritish Journal of Clinical Pharmacology, 1993
- CYP1A1: Friend or Foe?Drug Metabolism Reviews, 1993
- Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptorBiochemical and Biophysical Research Communications, 1992
- Consideration of CASE predictions of genotoxic carcinogenesis for omeprazole, methapyrilene and azathioprineMutation Research/Environmental Mutagenesis and Related Subjects, 1992
- P450IA2 and omeprazoleGastroenterology, 1992
- Omeprazole Drug Interaction StudiesClinical Pharmacokinetics, 1991
- Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450Gastroenterology, 1990
- Human cytochrome P450 isoformsGastroenterology, 1990
- The interaction of omeprazole with rat liver cytochrome P450-mediated monooxygenase reactions in vitro and in vivoBiochemical Pharmacology, 1988